{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:15:59Z","timestamp":1793740559167,"version":"4.6.1"},"reference-count":11,"publisher":"Japanese Circulation Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2025,6,10]]},"DOI":"10.1253\/circrep.cr-25-0031","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T22:15:56Z","timestamp":1744928156000},"page":"442-450","source":"Crossref","is-referenced-by-count":10,"title":["Real-World Clinical Impact of Tafamidis on Transthyretin Amyloid Cardiomyopathy\u3000\u2015 A Decade of Experience From a Community-Based Hospital (2015\u20132024) \u2015"],"prefix":"10.1253","volume":"7","author":[{"given":"Toru","family":"Kubota","sequence":"first","affiliation":[{"name":"Division of Cardiology, Cardiovascular and Aortic Center, Saiseikai Fukuoka General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiya","family":"Kato","sequence":"additional","affiliation":[{"name":"Division of Pathology, Saiseikai Fukuoka General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Nagatomo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular and Aortic Center, Saiseikai Fukuoka General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Ishikita","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular and Aortic Center, Saiseikai Fukuoka General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Nozoe","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular and Aortic Center, Saiseikai Fukuoka General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Suematsu","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular and Aortic Center, Saiseikai Fukuoka General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kitaoka H, Izumi C, Izumiya Y, Inomata T, Ueda M, Kubo T, et al. JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis. <i>Circ J<\/i> 2020; 84: 1610\u20131671.","DOI":"10.1253\/circj.CJ-20-0110"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tsutsui Y, Kubota T, Kato S, Nozoe M, Suematsu N, Okabe M, et al. Utility of <sup>99 m<\/sup>Tc-pyrophosphate scintigraphy in diagnosing transthyretin cardiac amyloidosis in real-world practice. <i>Circ Rep<\/i> 2019; 1: 277\u2013285.","DOI":"10.1253\/circrep.CR-19-0015"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. <i>N Engl J Med<\/i> 2018; 379: 1007\u20131016.","DOI":"10.1056\/NEJMoa1805689"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Endo J, Sano M, Izumiya Y, Tsujita K, Nakamura K, Tahara N, et al. A statement on the appropriate administration of tafamidis in patients with transthyretin cardiac amyloidosis. <i>Circ J<\/i> 2019; 84: 15\u201317.","DOI":"10.1253\/circj.CJ-19-0811"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. <i>Bone Marrow Transplant<\/i> 2013; 48: 452\u2013458.","DOI":"10.1038\/bmt.2012.244"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Grogan M, Scott CG, Kyle RA, Zeldenrust SR, Gertz MA, Lin G, et al. Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system. <i>J Am Coll Cardiol<\/i> 2016; 68: 1014\u20131020.","DOI":"10.1016\/j.jacc.2016.06.033"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gillmore JD, Damy T, Fontana M, Hutchinson M, Lachmann HJ, Martinez-Naharro A, et al. A new staging system for cardiac transthyretin amyloidosis. <i>Eur Heart J<\/i> 2018; 39: 2799\u20132806.","DOI":"10.1093\/eurheartj\/ehx589"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nakashima N, Takashio S, Morioka M, Nishi M, Yamada T, Hirakawa K, et al. A simple staging system using biomarkers for wild-type transthyretin amyloid cardiomyopathy in Japan. <i>ESC Heart Fail<\/i> 2022; 9: 1731\u20131739.","DOI":"10.1002\/ehf2.13847"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ochi Y, Kubo T, Baba Y, Sugiura K, Miyagawa K, Noguchi T, et al. Early experience of tafamidis treatment in Japanese patients with wild-type transthyretin cardiac amyloidosis from the Kochi amyloidosis cohort. <i>Circ J<\/i> 2022; 86: 1121\u20131128.","DOI":"10.1253\/circj.CJ-21-0965"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Takashio S, Morioka M, Ishii M, Morikawa K, Hirakawa K, Hanatani S, et al. Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild-type transthyretin amyloid cardiomyopathy. <i>ESC Heart Fail<\/i> 2023; 10: 2319\u20132329.","DOI":"10.1002\/ehf2.14380"},{"key":"11","unstructured":"11. Ministry of Health, Labour and Welfare, Japan. National survey on amyloidosis in Japan (2016 Health and Labour Sciences Research Grant). https:\/\/mhlw-grants.niph.go.jp\/system\/files\/2016\/162051\/201610043B_upload\/201610043B0010.pdf (in Japanese)."}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/7\/6\/7_CR-25-0031\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T03:27:30Z","timestamp":1749871650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/7\/6\/7_CR-25-0031\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-25-0031","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"article-number":"CR-25-0031"}}